Co-Diagnostics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2018 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Co-Diagnostics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2018 to Q2 2024.
Co-Diagnostics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.5M, a 30.9% decline year-over-year.
Co-Diagnostics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $7.07M, a 21.2% decline year-over-year.
Co-Diagnostics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $8.34M, a 10.5% increase from 2022.
Co-Diagnostics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.54M, a 36.9% increase from 2021.
Co-Diagnostics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.51M, a 101% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$7.07M	$1.5M	-$670K	-30.9%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$7.74M	$1.57M	-$598K	-27.6%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$8.34M	$1.83M	-$578K	-24.1%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-14
Q3 2023	$8.92M	$2.17M	-$58.3K	-2.61%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$8.97M	$2.17M	+$637K	+41.5%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023	$8.34M	$2.17M	+$794K	+57.7%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	$7.54M	$2.4M	+$746K	+45%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-14
Q3 2022	$6.8M	$2.23M	+$819K	+58.1%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	$5.98M	$1.53M	+$606K	+65.3%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022	$5.37M	$1.38M	-$138K	-9.12%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	$5.51M	$1.66M	+$1.09M	+191%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-16
Q3 2021	$4.42M	$1.41M	+$368K	+35.3%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-10
Q2 2021	$4.05M	$927K	+$236K	+34.1%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11
Q1 2021	$3.82M	$1.51M	+$1.08M	+250%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-12
Q4 2020	$2.74M	$571K	-$27.5K	-4.6%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-24
Q3 2020	$2.77M	$1.04M	+$767K	+278%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-12
Q2 2020	$2M	$691K	+$565K	+447%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020	$1.43M	$433K	+$345K	+393%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-13
Q4 2019	$1.09M	$598K			Oct 1, 2019	Dec 31, 2019	10-K	2021-03-25
Q3 2019		$276K			Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-16
Q2 2019		$126K	-$87.8K	-41%	Apr 1, 2019	Jun 30, 2019	10-Q	2019-08-14
Q1 2019		$87.8K			Jan 1, 2019	Mar 31, 2019	10-Q	2019-05-14
Q2 2018		$214K			Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.